DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,520,107 | +9.4% | 86,740 | +5.8% | 0.32% | +10.3% |
| Q2 2023 | $19,676,700 | +0.7% | 81,986 | +5.7% | 0.29% | -5.8% |
| Q1 2023 | $19,548,498 | -5.0% | 77,561 | +0.0% | 0.31% | -11.0% |
| Q4 2022 | $20,582,741 | +4.9% | 77,548 | +2.1% | 0.35% | -6.0% |
| Q3 2022 | $19,612,000 | +14.5% | 75,930 | +12.4% | 0.37% | +12.5% |
| Q2 2022 | $17,121,000 | +6.0% | 67,533 | +22.7% | 0.33% | +19.8% |
| Q1 2022 | $16,150,000 | +103.8% | 55,055 | +128.6% | 0.27% | +113.3% |
| Q4 2021 | $7,924,000 | +0.8% | 24,083 | -6.8% | 0.13% | -15.2% |
| Q3 2021 | $7,864,000 | +14.9% | 25,832 | +1.2% | 0.15% | +11.0% |
| Q2 2021 | $6,847,000 | +15.2% | 25,514 | -3.4% | 0.14% | +2.3% |
| Q1 2021 | $5,944,000 | -3.7% | 26,407 | -5.0% | 0.13% | -13.6% |
| Q4 2020 | $6,173,000 | -0.7% | 27,791 | -3.7% | 0.15% | -14.4% |
| Q3 2020 | $6,216,000 | +5.3% | 28,867 | -13.5% | 0.18% | -2.7% |
| Q2 2020 | $5,905,000 | +45.3% | 33,391 | +13.7% | 0.18% | +11.4% |
| Q1 2020 | $4,065,000 | -9.4% | 29,373 | +0.5% | 0.17% | +14.5% |
| Q4 2019 | $4,487,000 | +10.1% | 29,237 | +3.6% | 0.14% | -20.3% |
| Q3 2019 | $4,075,000 | +20.3% | 28,215 | +19.1% | 0.18% | +19.0% |
| Q2 2019 | $3,387,000 | +54.3% | 23,697 | +42.6% | 0.15% | +36.6% |
| Q1 2019 | $2,195,000 | +28.2% | 16,623 | +0.1% | 0.11% | +12.0% |
| Q4 2018 | $1,712,000 | -1.0% | 16,604 | +4.3% | 0.10% | +13.6% |
| Q3 2018 | $1,730,000 | +8.7% | 15,919 | -1.3% | 0.09% | +2.3% |
| Q2 2018 | $1,592,000 | -0.3% | 16,131 | -1.1% | 0.09% | -5.5% |
| Q1 2018 | $1,597,000 | +1.7% | 16,310 | -3.6% | 0.09% | +2.2% |
| Q4 2017 | $1,571,000 | +8.6% | 16,921 | +0.4% | 0.09% | +1.1% |
| Q3 2017 | $1,446,000 | +1.5% | 16,861 | -0.1% | 0.09% | -4.3% |
| Q2 2017 | $1,425,000 | -8.6% | 16,884 | -7.4% | 0.09% | -12.4% |
| Q1 2017 | $1,559,000 | -11.3% | 18,232 | -19.3% | 0.10% | -18.0% |
| Q4 2016 | $1,758,000 | +6.4% | 22,585 | +7.1% | 0.13% | +2.4% |
| Q3 2016 | $1,652,000 | -15.2% | 21,078 | +9.3% | 0.12% | -16.7% |
| Q2 2016 | $1,947,000 | +5.2% | 19,280 | -1.2% | 0.15% | +5.6% |
| Q1 2016 | $1,851,000 | +1.8% | 19,510 | -0.3% | 0.14% | +2.2% |
| Q4 2015 | $1,818,000 | +7.6% | 19,570 | -1.3% | 0.14% | +8.6% |
| Q3 2015 | $1,690,000 | -0.4% | 19,830 | +0.0% | 0.13% | +14.3% |
| Q2 2015 | $1,697,000 | +0.8% | 19,829 | +0.0% | 0.11% | -0.9% |
| Q1 2015 | $1,683,000 | -1.1% | 19,828 | -0.1% | 0.11% | -5.0% |
| Q4 2014 | $1,702,000 | +10.2% | 19,853 | -2.3% | 0.12% | -20.1% |
| Q3 2014 | $1,544,000 | -3.5% | 20,323 | +0.0% | 0.15% | -3.2% |
| Q2 2014 | $1,600,000 | +2.0% | 20,322 | -2.8% | 0.15% | -2.5% |
| Q1 2014 | $1,569,000 | -3.6% | 20,916 | -0.8% | 0.16% | -8.7% |
| Q4 2013 | $1,628,000 | +12.0% | 21,089 | +0.6% | 0.17% | -8.5% |
| Q3 2013 | $1,453,000 | +3.6% | 20,967 | -5.4% | 0.19% | +3.3% |
| Q2 2013 | $1,403,000 | – | 22,170 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |